//img.uscri.be/pth/bcece2f807d672a1fbaf89f69864030f1c80c60f
Cet ouvrage fait partie de la bibliothèque YouScribe
Obtenez un accès à la bibliothèque pour le lire en ligne
En savoir plus

After Capturing the U.S. Market, Frost & Sullivan Recognizes Naviscan's Pioneering Organ-Specific PET Scanner's Potential in Europe

3 pages
After Capturing the U.S. Market, Frost & Sullivan Recognizes Naviscan's Pioneering Organ-Specific PET Scanner's Potential in Europe PR Newswire MOUNTAIN VIEW, California, June 6, 2012 - In addition to high resolution and sensitivity, Naviscan's product provides incomparable workflow integration and economic benefits MOUNTAIN VIEW, California, June 6, 2012 /PRNewswire/ -- Based on its recent analysis of the organ-specific molecular imaging market, Frost & Sullivan recognizes Naviscan Inc. (Naviscan) with the 2012 European Frost & Sullivan Award for Product Quality Leadership for its organ-specific PET scanner. With its main application in Positron Emission Mammography (PEM), the product offers multiple benefits to the customer over competing products. Naviscan's PET scanner offers numerous advantages in a wide variety of clinical applications, such as detection, staging, monitoring response to neo-adjuvant chemotherapy and re-staging of breast cancer, detection of peripheral tumors, and screening for recurrent melanoma. Applications that are showing promise in ongoing clinical trials include osteoarthritis and rheumatoid arthritis. With its ability to position the detectors in close proximity to the organ imaged— achieving higher resolution than a whole-body (WB) PET scanner—the product is simply superior in quality.
Voir plus Voir moins
After Capturing the U.S. Market, Frost &
Sullivan Recognizes Naviscan's Pioneering
Organ-Specific PET Scanner's Potential in
Europe
PR Newswire
MOUNTAIN VIEW, California, June 6, 2012
- In addition to high resolution and sensitivity, Naviscan's product provides
incomparable workflow integration and economic benefits
MOUNTAIN VIEW, California
,
June 6, 2012
/PRNewswire/ -- Based on its recent
analysis of the organ-specific molecular imaging market, Frost & Sullivan
recognizes Naviscan Inc. (Naviscan) with the 2012 European Frost & Sullivan
Award for Product Quality Leadership for its organ-specific PET scanner. With
its main application in Positron Emission Mammography (PEM), the product
offers multiple benefits to the customer over competing products.
Naviscan's PET scanner offers numerous advantages in a wide variety of clinical
applications, such as detection, staging, monitoring response to neo-adjuvant
chemotherapy and re-staging of breast cancer, detection of peripheral tumors,
and screening for recurrent melanoma. Applications that are showing promise
in ongoing clinical trials include osteoarthritis and rheumatoid arthritis. With its
ability to position the detectors in close proximity to the organ imaged—
achieving higher resolution than a whole-body (WB) PET scanner—the product
is simply superior in quality.
Naviscan's intelligent design, including advanced photonics, biopsy guidance
software and cutting-edge visualization software, MIMViewer™ PEM
workstation, which was developed by MIMvista Software™, helps deliver high-
quality 3D tomographic images with excellent spatial resolution. While the
existing conventional screening methods for breast cancer produce results of
80 to 91 percent sensitivity, PEM offers 93 percent sensitivity and 93 percent
specificity. The visualization software is characteristic of its user-friendly
interface with options for creating customized images with attention to regions
of interest that can be saved as DICOM files to any PACS system.
"The proven accuracy, high sensitivity and specificity of the scanner in the
detection of lesions, particularly for breast cancer, helps the physicians make
confident and informed diagnosis," said Frost & Sullivan Research Analyst
Kaavya Karunanithi. "This helps in eliminating the number of false positives that
lead to unnecessary biopsies."
Further, the compact nature of the product offers additional economic benefits
by reducing maintenance and installation charges when compared to WB PET
or MRI scanners. Naviscan's design team has made the PET scanner very
portable to enable remote diagnostics.
"The company's major focus on quality in the past five years has enabled its
PET scanner to achieve high market penetration in the
USA
by capitalizing on
numerous peer-reviewed publications from multicenter prospective clinical
trials that showcase the high sensitivity, specificity and accuracy that the
product delivers," notes Karunanithi. "It is with this reputation that the product